Western Blotting Market Report 2026

Western Blotting Market Overview

• Western Blotting market size has reached to $1.39 billion in 2025 • Expected to grow to $2.14 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: The Increasing Prevalence Of HIV Fueling Growth Due To Rising Need For Accurate Detection And Treatment • Market Trend: Innovative Imaging Systems Advancing Western Blotting And Protein Quantification Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Western Blotting Market?

Western blotting is a laboratory technique to detect and analyze specific samples' proteins. It involves separating proteins using gel electrophoresis, transferring them onto a membrane, and identifying the target protein with antibodies. This method is valuable for studying protein expression, molecular weight, and post-translational modifications. The main products in the western blotting market are instruments and consumables. Western blotting instruments refer to specialized laboratory equipment used to perform the Western blot technique, which detects and analyzes specific proteins in a sample. The various applications include scientific research, medical diagnostics, agricultural application, food and beverages, and others and different end-users encompass academic and research institutes, pharmaceutical and biotechnology companies, diagnostic centers, and others.

What Is The Western Blotting Market Growth Forecast?

The western blotting market size is expected to see strong growth in the next few years. It will grow to $2.14 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for biomarker-based diagnostics, expansion of proteomics research, growing automation in laboratory workflows, rising focus on high-throughput protein analysis, increasing use of western blotting in clinical research. Major trends in the forecast period include increasing adoption of automated western blot systems, rising demand for high-sensitivity protein detection, growing use of ready-to-use reagent kits, expansion of digital imaging and analysis tools, enhanced focus on reproducibility and standardization.

Global Western Blotting Market Segmentation

1) By Product: Instruments, Consumables 2) By Application: Scientific Research, Medical Diagnostics, Agricultural Application, Food And Beverages, Other Applications 3) By End-Users: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Centers, Other End-Users Subsegments: 1) By Instruments: Gel Electrophoresis Instruments, Blotting Systems, Imagers 2) By Consumables: Reagents, Kits

What Is The Driver Of The Western Blotting Market?

The rising prevalence of human immunodeficiency virus (HIV) is expected to propel the growth of the western blotting market going forward. Human immunodeficiency virus (HIV) refers to a virus that attacks the body's immune system, weakening its ability to fight infections and diseases. The prevalence of HIV is due to a lack of awareness and education about prevention methods, leading to increases in the risk of transmission. Western blotting is widely used for HIV diagnosis and confirmation, making it essential in detecting the virus. It helps in early detection and treatment, supporting better disease management. For instance, in October 2024, according to Gov.UK, a UK-based government agency, in 2023, there were 6,402 HIV diagnoses in the UK (excluding Northern Ireland), marking a 46% increase from 4,379 cases in 2022. Therefore, the rising prevalence of human immunodeficiency virus (HIV) is driving the growth of the western blotting industry.

Key Players In The Global Western Blotting Market

Major companies operating in the western blotting market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Merck KGaA, GE Healthcare, EMD Millipore, PerkinElmer Inc., Bio-Rad Laboratories, GeneTex Inc., GenScript Biotech, Abcam plc, Promega Corporation, Takara Bio Inc., Cell Signaling Technology, Proteintech Group Inc., Cygnus Technologies, Santa Cruz Biotechnology, Abnova Corporation, Azure Biosystems Inc., Leinco Technologies Inc., LI-COR Biosciences GmbH, Novus Biologicals LLC

Global Western Blotting Market Trends and Insights

Major companies operating in the western blotting market are focusing on developing innovative imaging systems, such as complementary metal-oxide-semiconductor (CMOS) digital imaging technology and stain-free imaging technology to enhance image clarity, protein quantification precision, and overall throughput in research applications. CMOS digital imaging technology is a high-sensitivity imaging technique that captures gel and western blot images using complementary metal oxide semiconductor sensors, while stain-free imaging technology is a method that enables total protein normalization without the need for additional probing or stripping, simplifying the western blot workflow. For instance, in July 2024, Bio-Rad, a US-based biotechnology company, launched the ChemiDoc Go Imaging System, a compact imaging system that employs CMOS digital imaging and Stain-Free Imaging technology. This system improves western blotting and gel imaging by boosting sensitivity, accuracy, and workflow efficiency. It is well-suited for life science research applications such as protein quantification and quality control.

What Are Latest Mergers And Acquisitions In The Western Blotting Market?

In September 2024, Leinco Technologies Inc., a US-based biotechnology company, acquired QED Biosciences for an undisclosed amount. Through this acquisition, Leinco Technologies aims to expand its portfolio of high-quality antibodies, reagents, and development services, strengthening its position in the global antibody market while enhancing its offerings for research and in vitro diagnostics (IVD) applications, fostering innovation, and delivering greater value to researchers and clinicians worldwide. QED Biosciences is a US-based biotech company specializing in antibodies and recombinant proteins used in western blotting.

Regional Outlook

North America was the largest region in the western blotting market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Western Blotting Market?

The western blotting market consists of revenues earned by entities by providing services such as sample preparation, custom assay development, equipment maintenance, antibody probing, and antibody probing. The market value includes the value of related goods sold by the service provider or included within the service offering. The western blotting market also includes sales of transfer membranes, protein markers, chemiluminescent substrates, power supplies, and secondary antibodies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.